Notices and Activity Reports

April 13 (Sat) Regular study meeting was held

On April 13 (Sat), the monthly study meeting was held in Osaka. Dr. Yoshiyoshi Tanaka, Director of Tanaka Clinic and Representative Director of the study group, explained the introduction of new tests, and Dr. Yuichi Kawai, Director of Osaka Area Block Chief, Kataoka Internal Medicine Clinic, presented a case study. The study group holds a monthly study session with doctors belonging to the study group. We have established an environment in which distant doctors can participate via videoconference, and we are constantly exchanging opinions to create a system that allows patients to receive transplants with peace of mind. Please look forward to the results of our research on intestinal flora transplantation, which is evolving and developing day by day.

group photo

Commentary by Dr. Tanaka

Case report by Dr. Kawai

Articles about other Notices and Activity Reports

April 03, 2024

【Event】 Dr. Shirotani will speak at the 7th Annual Conference of the Japanese Society of Preemptive Clinical Medicine

Dr. Masahiko Shirotani, Executive Director of the Luke’s Ashiya Clinic, will deliver a special lecture at the 7th Annual Conference of the Japanese Society of Preemptive Medicine to be held on June 22 (Sat.) and 23 (Sun.), 2024. Dr. Zen Tanaka, President of Tanaka Clinic, Nizenkai Medical Corporation, will be the chairperson. Lecture Contents Special […]

March 04, 2024 Academic Conference

〈Registration Start〉8th Annual Conference

We are pleased to announce that the 8th Annual Conference will be held again this year. (Venue and online)Anyone is welcome to attend, not only healthcare professionals, but also the general public, students, etc. Date and Time Sunday, September 22, 2024Start 11:00 am (Registration 10:30 am) – Closing at 5:00 pm *General Meeting: Held before […]

February 04, 2024

Interview with Goro Tsukamoto at the 7th Annual Meeting

‘Gut Flora Transplantation Clinical Study Group of Experts〜Aiming for easier access to treatment, we are challenging research and development.Pharmacist, Doctor of Engineering Goro Tsukamoto: Former Director and General Manager of Drug Discovery Research Institute, Bell Boss, Former Visiting Professor, University of Pittsburgh, USA, Former Professor, Nagaoka University of Technology The world’s first migraine drug, invented […]